G1 Therapeutics Inc

NASDAQ:GTHX   3:59:59 PM EDT
22.69
+0.12 (+0.53%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)952.04M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.77 Million
Adjusted EPS-$1.06
See more estimates
10-Day MA$23.43
50-Day MA$23.97
200-Day MA$18.54
See more pivots

G1 Therapeutics Inc Stock, NASDAQ:GTHX

700 Park Offices Drive, Suite 200, Research Triangle Park, North Carolina 27709
United States of America
Phone: +1.919.213.9835
Number of Employees: 122

Description

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.